Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Post Procedural Erythema. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States, Canada
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Multi-site, Prospective, Observational Study of Autologous Hair Follicle Secretome (aHFS) as an Adjunct to Medical Aesthetic Procedures
Overview
Non-interventional, multi-site, prospective, open-label, observational, real-world study of autologous hair follicle secretome use.
Detailed description
This non-interventional, observation study is to collect real-world data on the use of an autologous, hair follicle derived secretome topical cosmetic product following various medical aesthetic procedures.
Primary outcome measures
- Post-Procedure Symptoms [Time frame: 1-7 days]
- Downtime Questionnaire [Time frame: 1-7 days]
Eligibility criteria
Inclusion criteria
- Male and Female
- Ages: 18-60
- Any Fitzpatrick skin type
- Planning a medical aesthetic procedure
- For subjects receiving hair procedures (closed to enrollment):
- Androgenic alopecia
- Traction alopecia
- Scarring alopecia
- Stable use of any medication or supplement for hair loss, including finasteride, any other 5 α-reductase inhibitor, minoxidil, steroids, or hormonal products, during the 3 months prior to enrollment in the study is allowed.
- No intention to start new hair growth medications or change dose of hair growth medications from the time of consent through the end of the study follow-up period.
- Undergoing one of the following medical aesthetic procedures:
- Laser resurfacing of the face (ablative or non-ablative) or Ellacor of the face (Ellacor closed to enrollment)
- Tixel of the face
- Keralase of the scalp (scalp treatment closed to enrollment)
- Acne Scars and Surgery scars, either old or new as long as old scars are also being treated with ablative or non-ablative laser or microneedling (e.g. abdominoplasty, breast reduction/ reconstruction/enhancement, post-weight loss, etc.
- Planning to use Acorn Autologous Hair Follicle Secretome cosmetic product
Exclusion criteria
- Pregnant or Breastfeeding
- Participation in an interventional clinical trial in the last 30 days
- Use of other topical cosmetic products that may confound results
- Use of retinoids within 7 days prior to facial procedure
- For those receiving hair treatment, must not have had a hair transplant in the treatment area within the past 12 months
- Any health condition that in the investigator's opinion should preclude participation in study
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
United States · 31 centers
- Skin Wellness Dermatology — Birmingham
- BelleSante — Scottsdale
- Arash Moradzadeh MD — Beverly Hills
- Glenn Vallecillos, MD Inc — Beverly Hills
- Behr Laser & Skin Care Center — Fresno
- Aesthetics By Dr. Lee — Granite Bay
- Carlo Honrado, MD, FACS — Los Angeles
- Marcus Medical — Manhattan Beach
- … and 23 more centers
Canada · 9 centers
- Dr. Jean Carruthers Cosmedic — Vancouver
- Dr. Amber Bocknek — Aurora
- Sanjeev Goel MD Peak Human — Brampton
- Compass Dermatology — Toronto
- Rejuuv — Toronto
- Dr. Nowell Solish Cosmetic Dermatologist — Toronto
- FCP Dermatology — Toronto
- BeSpoke Wellness — Toronto
- … and 1 more center
Identifiers
NCT: NCT06477172 · ACN-101